nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2010-14-1-50-55nefr-1202Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESЭПИДЕМИОЛОГИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮEPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE PATIENTS WITH CHRONIC HEART FAILUREСеровВ. А.SerovV. A.

кафедра терапии и профессиональных болезней меди­цинского факультета

432072, г. Ульяновск, ул. 40-летия Победы, д. 14, кв. 62. Тел.: (8422) 55-27-08

Valery_serov@mail.ruШутовА. М.ShutovA. M.

кафедра терапии и профессиональных болезней меди­цинского факультета

МензоровМ. В.MenzorovM. V.

кафедра терапии и профессиональных болезней меди­цинского факультета

МакееваЕ. Р.MakeevaE. R.

кафедра терапии и профессиональных болезней меди­цинского факультета

СероваД. В.SerovaD. V.

кафедра терапии и профессиональных болезней меди­цинского факультета

Ульяновский государственный университетRussian Federation2010100120101415055Copyright © Серов В.А., Шутов А.М., Мензоров М.В., Макеева Е.Р., Серова Д.В., 20102010Серов В.А., Шутов А.М., Мензоров М.В., Макеева Е.Р., Серова Д.В.Serov V.A., Shutov A.M., Menzorov M.V., Makeeva E.R., Serova D.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1202

Имеющиеся данные свидетельствуют, что распространенность хронической болезни почек (ХБП) среди больных с хронической сердечной недостаточностью (ХСН) составляет от 9,2 при ХСН, обусловленной врожденными пороками сердца, до 71,2% – при ХСН, обусловленной ишемической болезнью сердца (ИБС) и артериальной гипертонией. Снижение функции почек ассоциировано с возрастом и функциональным классом ХСН. Однако, если низкую частоту ХБП среди больных с ХСН с врожденными пороками сердца можно объяснить молодым возрастом и нетяжелой ХСН, то причины значительного различия в распространенности ХБП у больных с ХСН, обусловленной ИБС и артериальной гипертонией, остаются неясными. Требует уточнения распространенность ХБП как среди больных с ХСН в целом, так и в отдельных группах больных. Необходимо уточнение причины гендерных особенностей ХСН, ассоциированной с ХБП. Целесообразно проведение не только клинических, но и клинико-экономических исследований, при этом следует учитывать, что результаты, полученные зарубежными исследователями, нельзя безоговорочно использовать в России, так как имеются значительные отличия как в организации медицинской помощи населению, так и в спектре медикаментозных препаратов, особенно препаратов-дженериков, используемых при лечении ХСН.

Available data indicate that the prevalence of chronic kidney disease (CKD) among patients with chronic heart failure (CHF) ranges from 9.2 for chronic heart failure caused by congenital heart disease, up 71.2% with chronic heart failure caused by coronary heart disease (CHD) and arterial hypertension. Reduced renal function is associated with age and functional class of CHF. However, if the low frequency of CKD among patients with CHF with congenital heart disease can be attributed to young age and non-severe heart failure, the reasons for substantial differences in the prevalence of CKD in patients with CHF due to ischemic heart disease and hypertension, remains unclear. Requires clarification as the prevalence of CKD among patients with CHF in general and in specific groups of patients. Should clarify the causes of gender-specific heart failure associated with CKD. It is advisable to conduct not only clinical but also the clinical and economic studies, it should be borne in mind that the results of foreign researchers, can not be fully used in Russia as there are significant differences in the organization of medical care, and in the range of medicinal products especially drugs, generics used to treat heart failure.

хроническая болезнь почекхроническая сердечная недостаточностьэпидемиологияchronic kidney diseasechronic heart failureepidemiologyReferencesRosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115 (5): e 69–171Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115 (5): e 69–171Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106 (16): 269–275Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106 (16): 269–275Фомин ИВ, Беленков ЮН, Мареев ВЮ. Распространенность ХСН в Европейской части Российской федерации – данные ЭПОХА-ХСН. Сердечная недостаточность 2006; 7 (1): 4–7Фомин ИВ, Беленков ЮН, Мареев ВЮ. Распространенность ХСН в Европейской части Российской федерации – данные ЭПОХА-ХСН. Сердечная недостаточность 2006; 7 (1): 4–7Rodrнguez-Artalejo F, Banegas Banegas JR, Guallar-Castillуn P. Epidemiology of heart failure. Rev Esp Cardiol 2004; 57 (2): 163-170Rodrнguez-Artalejo F, Banegas Banegas JR, Guallar-Castillуn P. Epidemiology of heart failure. Rev Esp Cardiol 2004; 57 (2): 163-170Pocock SJ, Wang D, Pfeffer MA et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27 (1): 65–75Pocock SJ, Wang D, Pfeffer MA et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27 (1): 65–75Henkel DM, Redfield MM, Weston SA et al. Death in heart failure: a community perspective. Circ Heart Fail 2008; 1 (2): 91–97Henkel DM, Redfield MM, Weston SA et al. Death in heart failure: a community perspective. Circ Heart Fail 2008; 1 (2): 91–97Chae CU, Albert CM, Glynn RJ et al. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol 2003; 92 (6): 682–686Chae CU, Albert CM, Glynn RJ et al. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol 2003; 92 (6): 682–686Fаcila L, Bertomeu V, Bertomeu-Gonzаlez V et al. Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) 2009; 11 (6): 303–308Fаcila L, Bertomeu V, Bertomeu-Gonzаlez V et al. Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) 2009; 11 (6): 303–308ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112; e154–e235ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112; e154–e235Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007; 23 (1): 21–45Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007; 23 (1): 21–45Национальные Рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007; 1: 4–41Национальные Рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007; 1: 4–41ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed incollaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 2008; 29 (19): 2388–2442ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed incollaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 2008; 29 (19): 2388–2442Amsalem Y, Garty M, Schwartz R et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008; 29 (8): 1029–1036Amsalem Y, Garty M, Schwartz R et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008; 29 (8): 1029–1036Dimopoulos K, Diller GP, Koltsida E et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008; 117 (18): 2320–2328Dimopoulos K, Diller GP, Koltsida E et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008; 117 (18): 2320–2328Hillege HL, Nisch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671–678Hillege HL, Nisch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671–678Ghali JK, Wikstrand J, Van Veldhuisen DJ et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Fail 2009; 15 (4): 310–318Ghali JK, Wikstrand J, Van Veldhuisen DJ et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Fail 2009; 15 (4): 310–318Ezekowitz J, McAlister FA, Humphries KH et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44 (8): 1587–1592Ezekowitz J, McAlister FA, Humphries KH et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44 (8): 1587–1592Go AS, Yang J, Ackerson LM et al. Hemoglobin lel, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113 (23): 2713–2723Go AS, Yang J, Ackerson LM et al. Hemoglobin lel, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113 (23): 2713–2723Ahmed A, Rich MW, Sanders PW et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99 (3): 393–398Ahmed A, Rich MW, Sanders PW et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99 (3): 393–398Shiba N, Matsuki M, Takahashi J et al. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008; 72 (2): 173–178Shiba N, Matsuki M, Takahashi J et al. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008; 72 (2): 173–178de Silva R, Nikitin NP, Witte KK et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006; 27 (5): 569–581de Silva R, Nikitin NP, Witte KK et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006; 27 (5): 569–581McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109 (8): 1004–1009McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109 (8): 1004–1009Zamora E, Lupуn J, Urrutia A et al. Prognostic significance of creatinine clearance rate in patients with heart failure and normal serum creatinine. Rev Esp Cardiol 2007; 60 (12): 1315–1318Zamora E, Lupуn J, Urrutia A et al. Prognostic significance of creatinine clearance rate in patients with heart failure and normal serum creatinine. Rev Esp Cardiol 2007; 60 (12): 1315–1318Patel UD, Hernandez AF, Liang L et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines – Heart Failure Program study. Am Heart J 2008; 156 (4): 674–681Patel UD, Hernandez AF, Liang L et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines – Heart Failure Program study. Am Heart J 2008; 156 (4): 674–681Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S et al. Chronic Kidney Disease as an Independent Risk for Long-Term Adverse Outcomes in Patients Hospitalized With Heart Failure in Japan. Circ J 2009; 73 (8): 1442–1447Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S et al. Chronic Kidney Disease as an Independent Risk for Long-Term Adverse Outcomes in Patients Hospitalized With Heart Failure in Japan. Circ J 2009; 73 (8): 1442–1447Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005; 111 (10): 1270–1277Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005; 111 (10): 1270–1277Трошенькина ОВ, Серов ВА, Шутов АМ и соавт. Распространенность хронической болезни почек у больных с хронической сердечной недостаточностью. Актуальные проблемы медицинской науки и образования. Сборник трудов II межрегиональной научной конференции. ИИЦ ПГУ Пенза, 2009; 245–246Трошенькина ОВ, Серов ВА, Шутов АМ и соавт. Распространенность хронической болезни почек у больных с хронической сердечной недостаточностью. Актуальные проблемы медицинской науки и образования. Сборник трудов II межрегиональной научной конференции. ИИЦ ПГУ Пенза, 2009; 245–246Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461–470Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461–470Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53 (6): 982–992Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53 (6): 982–992Zhao WY, Zeng L, Zhu YH et al. A comparison of prediction equations for estimating glomerular filtration rate in Chinesepotential living kidney donors. Clin Transplant 2009; 23 (4): 469–475Zhao WY, Zeng L, Zhu YH et al. A comparison of prediction equations for estimating glomerular filtration rate in Chinesepotential living kidney donors. Clin Transplant 2009; 23 (4): 469–475Шабалин АВ. Гериатрическая кардиология. Диагностика и лечение хронической сердечной недостаточности у больных пожилого возраста. В: Оганов Р.Г., Фомина И.Г. Болезни сердца. Руководство для врачей. Литтерра, М., 2006; 1225–1242Шабалин АВ. Гериатрическая кардиология. Диагностика и лечение хронической сердечной недостаточности у больных пожилого возраста. В: Оганов Р.Г., Фомина И.Г. Болезни сердца. Руководство для врачей. Литтерра, М., 2006; 1225–1242Spiecker M. Heart failure in elderly patients. Exp Gerontol 2006; 41 (5): 549–551Spiecker M. Heart failure in elderly patients. Exp Gerontol 2006; 41 (5): 549–551Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci2007; 1100: 353-360Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci2007; 1100: 353-360Franzoni F, Ghiadoni L, Galetta F et al. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005; 18 (4 Pt 1): 510–516Franzoni F, Ghiadoni L, Galetta F et al. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005; 18 (4 Pt 1): 510–516Oxenham H, Sharpe N. Cardiovascular aging and heart failure.Eur J Heart Fail 2003; 5 (4): 427-434Oxenham H, Sharpe N. Cardiovascular aging and heart failure.Eur J Heart Fail 2003; 5 (4): 427-434Bursi F, Weston SA, Redfield MM et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296 (18): 2209–2216Bursi F, Weston SA, Redfield MM et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296 (18): 2209–2216Cheitlin MD. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol 2003; 12 (1): 9–13Cheitlin MD. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol 2003; 12 (1): 9–13O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50 (1): 1–13O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50 (1): 1–13Amann K, Tyralla K. Cardiovascular changes in chronic renal failure–pathogenesis and therapy. Clin Nephrol 2002; 58 Suppl 1: S62–72Amann K, Tyralla K. Cardiovascular changes in chronic renal failure–pathogenesis and therapy. Clin Nephrol 2002; 58 Suppl 1: S62–72Guеrin AP, Pannier B, Marchais SJ, London GM. Arterial structure and function in end-stage renal disease. Curr Hypertens Rep 2008; 10 (2): 107–111Guеrin AP, Pannier B, Marchais SJ, London GM. Arterial structure and function in end-stage renal disease. Curr Hypertens Rep 2008; 10 (2): 107–111Zhang L, Zhao F, Yang Y et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007; 49 (6): 786–792Zhang L, Zhao F, Yang Y et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007; 49 (6): 786–792Galvao M, Kalman J, DeMarco T et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 2006; 12 (2): 100–107Galvao M, Kalman J, DeMarco T et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 2006; 12 (2): 100–107Rosengren A, Hauptman P. Women, men and heart failure: a review. Heart Fail Monit 2008; 6 (1): 34–40Rosengren A, Hauptman P. Women, men and heart failure: a review. Heart Fail Monit 2008; 6 (1): 34–40Терещенко СН, Жиров ИВ. Хроническая сердечная недостаточность у женщин. Журнал Сердечная недостаточность 2008; 6: 295–298Терещенко СН, Жиров ИВ. Хроническая сердечная недостаточность у женщин. Журнал Сердечная недостаточность 2008; 6: 295–298Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004; 88 (5): 1321–1345Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004; 88 (5): 1321–1345O’Meara E, Clayton T, McEntegart MB et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 115 (24): 3111–3120O’Meara E, Clayton T, McEntegart MB et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 115 (24): 3111–3120Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 2006; 97 (8): 1228–1231Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 2006; 97 (8): 1228–1231Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49 (5): 572–577Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49 (5): 572–577Frazier CG, Alexander KP, Newby LK et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007; 49 (13): 1450–1458Frazier CG, Alexander KP, Newby LK et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007; 49 (13): 1450–1458Wiinber N, Hoegholm A, Christensen H et al. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8: 978–986Wiinber N, Hoegholm A, Christensen H et al. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8: 978–986Mahmoodzadeh S, Eder S, Nordmeyer J et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 2006; 20 (7): 926–934Mahmoodzadeh S, Eder S, Nordmeyer J et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J 2006; 20 (7): 926–934Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007; 116: 2747–2759Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007; 116: 2747–2759Reckelhoff JF, Yanes LL, Iliescu R et al. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 2005; 289 (5): F941–948Reckelhoff JF, Yanes LL, Iliescu R et al. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 2005; 289 (5): F941–948Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5 Suppl A: S3–S10Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5 Suppl A: S3–S10Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117Nitsch D, Felber Dietrich D, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21 (4): 935–944Nitsch D, Felber Dietrich D, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21 (4): 935–944Grabysa R, Cholewa M. Predictors of chronic kidney disease in hypertensive patients. Pol Merkur Lekarski 2008; 25 (145): 9–14Grabysa R, Cholewa M. Predictors of chronic kidney disease in hypertensive patients. Pol Merkur Lekarski 2008; 25 (145): 9–14Rogers JL, Mitchell AR, Maric C et al. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R794–R799Rogers JL, Mitchell AR, Maric C et al. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R794–R799Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res 2008; 31 (2): 71–79Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res 2008; 31 (2): 71–79Yanes LL, Sartori-Valinotti JC, Iliescu R et al. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 2009; 296 (4): F771–F779Yanes LL, Sartori-Valinotti JC, Iliescu R et al. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 2009; 296 (4): F771–F779Gandolfo MT, Verzola D, Salvatore F et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004; 56 (1): 1–14Gandolfo MT, Verzola D, Salvatore F et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004; 56 (1): 1–14Kang DH, Yu ES, Yoon KI, Johnson R. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164 (2): 679–688Kang DH, Yu ES, Yoon KI, Johnson R. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164 (2): 679–688Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl HB. Herzinsuffizienz – geschlechtsspezifische Aspekte? Internist (Berl) 2008; 49 (4): 422–428Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl HB. Herzinsuffizienz – geschlechtsspezifische Aspekte? Internist (Berl) 2008; 49 (4): 422–428Gross ML, Ritz E, Korsch M et al. Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. Kidney Int 2005; 67 (3): 849–857Gross ML, Ritz E, Korsch M et al. Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. Kidney Int 2005; 67 (3): 849–857Maric C, Sullivan S. Estrogens and the diabetic kidney. Gend Med 2008; 5 Suppl A: S103–113Maric C, Sullivan S. Estrogens and the diabetic kidney. Gend Med 2008; 5 Suppl A: S103–113Silverberg DS, Wexler D, Iaina A et al. Anemia, chronic renal disease and congestive heart failure – the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38 (2): 295–310Silverberg DS, Wexler D, Iaina A et al. Anemia, chronic renal disease and congestive heart failure – the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38 (2): 295–310

The authors declare that there are no conflicts of interest present.